This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

RELEASE DATE
30-Sep-2013
REGION
North America
Deliverable Type
Market Research
Research Code: 9A35-00-09-00-00
SKU: LS00229-NA-MR_17559
$450.00
In stock
SKU
LS00229-NA-MR_17559
$450.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics.

Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics in urine.

Table of Contents

This week's issue

Request Sample
Popular Topics

well intervention market

telematics market

composite materials market

flexible electronics market

surfactants market

plastic waste management market

smart grid market

activated carbon market

food preservatives market

commercial lighting market

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics in urine.
More Information
Deliverable Types Market Research
No Index Yes
Podcast No
Author Deborah Toscano
WIP Number 9A35-00-09-00-00
Is Prebook No